Clonidine hydrochloride
Clonidine hydrochloride.JPG

Clonidine hydrochloride

CLINICAL USE

Hypertension Migraine Gilles de la Tourette syndrome Menopausal flushing

DOSE IN NORMAL RENAL FUNCTION

Hypertension: 50–100 mcg 3 times a day, increasing gradually to 1.2 mg dailySlow IV: 150–300 mcg; maximum 750 mcg in 24 hoursMigraine, menopausal flushing, Gilles de la Tourette syndrome: 50–75 mcg twice daily

PHARMACOKINETICS

  • Molecular weight                           :266.6
  • %Protein binding                           :30–40
  • %Excreted unchanged in urine     : 40–60
  • Volume of distribution (L/kg)       :3–6
  • half-life – normal/ESRD (hrs)      :
  • 10 to 20
  • /41

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsAntidepressants: tricyclics antagonise hypotensive effect and also increase risk of hypertension on clonidine withdrawal; increased hypotensive effect with MAOIsBeta-adrenoreceptor antagonists: increased risk of hypertension on withdrawalCiclosporin: may increase ciclosporin levelsSympathomimetics: possibly increased risk of hypertension with adrenaline and noradrenaline; serious adverse effects reported with methylphenidate

    ADMINISTRATION

    Reconstition

    Route

    Oral, IV

    Rate of Administration

    Slow IV injection

    Comments

    Minimum volume for infusion 6–50 mcg/ mL in sodium chloride 0.9% or glucose 5% (UK Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3rd Edition, 2006)

    OTHER INFORMATION

    Use in renal impairment: clonidine plasma concentrations for a given dose are 2–3 times higher in patients with severe renal impairment; however, blood pressure control appears satisfactory and adverse effects are not increasedClonidine withdrawal: rebound hypertension if drug is abruptly withdrawnTricyclic antidepressants may decrease efficacy



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs